10-Q: Advent Technologies Faces Delisting Amid Liquidity Crisis
Sentiment:
Quarterly Report
Advent Technologies reported a net income for Q3 2025 driven by a one-time gain, but faces Nasdaq delisting, significant liquidity challenges, and a going concern warning.
Delay expectedThe company was delayed until October 2025 with the first monthly payment of €35,000 for the F.E.R. arbitration settlement, which was originally due September 1, 2025.The company did not make any repayments on the August 1, 2025, Promissory Note with Hudson Global Ventures LLC until October 2025, despite the first amortized payment being due September 1, 2025.
Capital raiseThe company entered into a Securities Purchase Agreement with Hudson Global Ventures LLC on August 1, 2025, for a $235,000 convertible promissory note and a pre-funded warrant.Another Securities Purchase Agreement was made with Hudson Global Ventures LLC on August 28, 2025, for a $418,000 convertible promissory note and a pre-funded warrant.On August 14, 2025, the company entered into a purchase agreement with Hudson Global Ventures LLC, granting the right to sell up to $52 million worth of common stock over a 24-month term.Between October 1, 2025, and October 31, 2025, the company issued 497,000 shares of Common Stock to Hudson under the Purchase Agreement for net proceeds of $443,000.Stockholders approved on October 22, 2025, the potential issuance and sale of 20% or more of the company's common stock under the Hudson Purchase Agreement, exceeding the Nasdaq Exchange Cap.The company explicitly states it plans to finance operations and repay existing and future liabilities through the sale of equity and/or debt securities and short-term/long-term loans, as its current cash is insufficient to fund operations for the next 12 months.
Worse than expectedRevenue for both the three and nine months ended September 30, 2025, significantly decreased compared to the prior year periods, indicating a substantial decline in core business sales.The company reported gross losses for both periods, worsening from prior year figures, which suggests deteriorating profitability from its core products and services.Net cash used in operating activities worsened significantly, indicating that the company's core operations are consuming more cash.The company explicitly stated that substantial doubt exists about its ability to continue as a going concern, highlighting severe liquidity issues.Nasdaq initiated delisting proceedings, moving the company's stock to the OTC market, which is a significant negative event for investor confidence and access to capital.
Summary
- Advent Technologies Holdings, Inc. reported a net income of $8.6 million for the three months ended September 30, 2025, a significant improvement from a net loss of $18.5 million in the prior year period.
- The net income was primarily driven by an $11.7 million gain on the settlement of a payable related to the bankruptcy of Advent Technologies A/S.
- Revenue for the three months ended September 30, 2025, decreased by 51.6% to $62,000 from $128,000 in the same period last year.
- For the nine months ended September 30, 2025, the company reported a net income of $1.55 million, compared to a net loss of $39.15 million in the prior year, also largely due to the one-time gain.
- Nine-month revenue decreased by 91.7% to $293,000 from $3.52 million in the prior year period.
- The company continues to face substantial doubt about its ability to continue as a going concern, with cash and cash equivalents of $468,000 and a negative net working capital of $16.0 million as of September 30, 2025.
- Nasdaq initiated delisting proceedings for Advent's common stock and warrants, effective October 30, 2025, due to non-compliance with listing rules, with trading now on the OTC market.
- Material weaknesses in internal control over financial reporting were identified across entity-level controls, financial statement close and reporting, and IT processes.
- The company secured a €34.5 million non-dilutive grant from the EU Innovation Fund for its RHyno Project and continues collaborations with Airbus and the U.S. Department of Defense.
Sentiment
Score: 2
Explanation: Despite a reported net income driven by a one-time gain, the underlying operational performance shows significant revenue decline and gross losses. The company faces severe liquidity issues, a going concern warning, and has been delisted from Nasdaq, indicating fundamental financial instability and high risk. The reliance on high-interest debt and continuous equity raises further highlights the precarious financial position.
Positives
- Reported a net income of $8.6 million for Q3 2025 and $1.55 million for the nine months ended September 30, 2025, primarily due to an $11.7 million gain on settlement of a payable.
- Operating loss significantly improved to $(2.37) million for Q3 2025 from $(7.93) million in Q3 2024.
- Received a €34.5 million non-dilutive grant from the EU Innovation Fund for the RHyno Project, aimed at developing and manufacturing fuel cells and electrolyzers.
- Continued collaboration with Airbus on a multi-million dollar joint benchmarking project for Ion Pair MEA technology, with Phase Two kicking off in February 2025.
- Secured new contracts with the U.S. Department of Defense totaling $2.2 million (Sept 2023) and $2.8 million (Dec 2023, adjusted to $2.15 million in Aug 2025) for optimizing and manufacturing the Honey Badger 50 portable fuel cell system.
- Entered into an enhanced license agreement with Triad National Security, LLC for Ion Pair technology, gaining exclusivity in marine, aviation, and portable power fields.
- Working capital deficit improved from $(26.08) million at December 31, 2024, to $(16.0) million at September 30, 2025.
Negatives
- Revenue decreased significantly by 51.6% for Q3 2025 and 91.7% for the nine months ended September 30, 2025, compared to the prior year periods.
- Gross loss worsened to $(375) thousand for Q3 2025 and $(848) thousand for the nine months ended September 30, 2025.
- Substantial doubt exists about the company's ability to continue as a going concern for the next twelve months due to insufficient cash and recurring operating losses.
- Nasdaq initiated delisting proceedings for the company's common stock and warrants, effective October 30, 2025, moving trading to the OTC market.
- The company has a negative net working capital position of $16.0 million as of September 30, 2025.
- Reliance on high-interest short-term loans from Agile Capital Funding, LLC with effective interest rates up to 292.82% per year.
- Advent Technologies A/S, a subsidiary, was declared bankrupt in July 2024, leading to discontinued operations.
- Delayed first payment for the F.E.R. arbitration settlement until October 2025.
- Outstanding contractual obligation with Shin-Etsu for 57,600 bipolar plates, with the contract on hold pending negotiations.
Risks
- Ability to maintain the listing of common stock and warrants on Nasdaq (already delisted to OTC).
- Ability to raise future financing to fund operations and meet obligations.
- Success in retaining or recruiting officers, key employees, or directors.
- Ability to control operational costs and manage growth profitably.
- Reliance on complex machinery for operations and production.
- Market willingness to adopt the company's technology.
- Ability to maintain relationships with customers.
- Potential impact of product recalls.
- Ability to compete within the industry.
- Increases in costs, disruption of supply, or shortage of raw materials.
- Risks associated with strategic alliances or acquisitions.
- Impact of unfavorable changes in U.S. and international regulations.
- Availability of and ability to meet terms for government grants and economic incentives.
- Ability to protect intellectual property rights.
- Market conditions and global and economic factors beyond control.
- Volatility of stock price and potential share dilution.
- Future exchange and interest rates.
- Material weaknesses in internal control over financial reporting could result in material misstatements.
- Cash shortfall could lead to failure to meet overdue and current obligations, potentially triggering liquidation actions.
Future Outlook
The company anticipates substantial increased demand for its fuel cell systems and MEAs as it scales up production and testing capabilities. It expects revenues to increase materially, weighted towards Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs). The successful development of the Advanced MEA, projected to deliver three times the power output of current products, is a key factor for future cost/kw performance improvement. The company expects to continue to be eligible for grant funding. However, the ability to meet liquidity needs depends on future capital raises and generating sufficient cash flow, which is uncertain.
Management Comments
- Management has concluded that substantial doubt exists with respect to the Company's ability to continue as a going concern for one year from the date the consolidated financial statements are issued.
- The company believes that its cash and cash equivalents as of September 30, 2025, of $0.4 million is not sufficient to fund operations and capital expenditures for the twelve months following the filing of this Quarterly Report on Form 10-Q, and the Company will need to obtain additional funding in the very near term, otherwise the Company may immediately substantially curtail or terminate its operations.
- Management is committed to successfully implementing the remediation plan for internal control weaknesses as promptly as possible, but can offer no assurance that these initiatives will ultimately have the intended effects.
Industry Context
Advent Technologies operates in the rapidly evolving fuel cell and hydrogen technology space, a competitive environment crucial for the global energy transition. The company's focus on Membrane Electrode Assembly (MEA) technology positions it as a critical component supplier for hydrogen fuel cells, which are expected to play an important role in decarbonizing carbon-intensive industries like aviation, maritime, and heavy-duty automotive. Collaborations with entities like Airbus and the U.S. Department of Defense highlight the industry's interest in advanced fuel cell solutions for diverse applications, from portable power to heavy transport. The EU Innovation Fund grant for the RHyno Project underscores significant governmental and institutional support for scaling up innovative fuel cell and electrolyzer manufacturing within Europe. However, the industry faces challenges in achieving cost-competitiveness and widespread adoption, which Advent aims to address through its next-generation MEA technology.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class II Director | Marc Seelenfreund | NA | 2025-10-29 | Resignation |
| Class II Director | Joseph Celia | NA | 2025-10-30 | Resignation |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Amendment | Stockholders approved an amendment to the 2021 Equity Incentive Plan to increase the number of shares of Common Stock issuable from 530,976 to 1,011,627 and to incorporate provisions for annual increases beginning January 1, 2027. | 2025-10-22 | Increases the pool of shares available for stock-based compensation, potentially impacting future dilution but also providing flexibility for employee incentives. |
| Shareholder Approval for Equity Issuance | Stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(d), the potential issuance and sale of 20% or more of the company's common stock pursuant to the purchase agreement with Hudson Global Ventures LLC. | 2025-10-22 | Enables the company to raise significant capital through equity sales to Hudson, but also signals potential for substantial shareholder dilution. |
Legal Proceedings
- Chris Kaskavelis, a former employee, filed a claim against Advent SA for €107,194.90 for unpaid wages, €612,206.40 for unpaid severance, €50,000 for moral damages, and related court expenses. The company denies the claims but has accrued $124,000 for unpaid wages.
- Settlement agreement reached with F.E.R. fischer Edelstahlrohre GmbH on July 1, 2025, to pay €5,366,625.55 (reducible to €4,366,625.55 if paid by June 30, 2026) to resolve an arbitration award. The first payment was delayed until October 2025.
- A purported shareholder filed a putative class action complaint on June 5, 2024, against former officers and directors of AMCI (the company's predecessor) alleging breach of fiduciary duty and unjust enrichment related to the 2021 SPAC transaction. The company is not named as a defendant.
Related Party Transactions
- Outstanding balances as of September 30, 2025, due to company executives and officers (Vassilios Gregoriou: $131,000, Gary Herman: $21,000, Emory S. De Castro: $235,000) primarily relate to short-term promissory notes with 5.00% annual interest, due by August 31, 2026.
Stakeholder Impact
- **Shareholders**: Significant dilution risk from ongoing equity raises (Hudson Purchase Agreement), Nasdaq delisting to OTC market impacting liquidity and investor confidence, and potential for further stock price volatility. The 1-for-30 reverse stock split in May 2024 already impacted share structure.
- **Employees**: Potential for job insecurity due to the company's going concern warning and need to curtail operations if funding is not secured. Legal proceedings from a former employee highlight potential labor disputes.
- **Creditors**: High risk due to the company's negative net working capital, overdue obligations, and going concern warning. High-interest short-term loans indicate a distressed borrowing environment.
- **Customers**: Potential for delays or inability to deliver contractual obligations if funding is not secured or operations are curtailed. However, collaborations with Airbus and US DoD suggest continued strategic importance.
- **Suppliers**: Risk of delayed payments or non-payment due to liquidity issues, as evidenced by the settlement with BASF and ongoing negotiations with Shin-Etsu.
Next Steps
- Obtain additional funding in the very near term to avoid curtailing or terminating operations.
- Continue efforts to generate sufficient revenue to fund operations and achieve profitability.
- Implement remediation plan to address identified material weaknesses in internal control over financial reporting, including hiring qualified professionals, enhancing IT systems, improving policies, and increasing testing.
- Defend vigorously against the legal claim filed by former employee Chris Kaskavelis.
- Continue negotiations with Shin-Etsu regarding the supply agreement for bipolar plates.
- Return 473 sqm of membrane (stored at BASF) and 4,000 sqm of membrane from its Patras facility to BASF by December 15, 2025, as per the terminated supply agreement.
Key Dates
| Date | Description |
|---|---|
| 2020-08-31 | Company entered into a Cooperative Research and Development Agreement (CRADA) with Triad National Security, LLC (TRIAD), Alliance for Sustainable Energy LLC (ASE), and Brookhaven Science Associates (BSA). |
| 2021-02-04 | AMCI Acquisition Corp. (AMCI) consummated the business combination with Legacy Advent, and AMCI changed its name to Advent Technologies Holdings, Inc. |
| 2021-06-25 | Company entered into a Share Purchase Agreement to acquire SerEnergy A/S and fischer eco solutions GmbH. |
| 2021-08-31 | Acquisition of SerEnergy and FES by the Company. |
| 2022-05-25 | Advent Technologies S.A. and UNI.FUND Mutual Fund entered into an agreement to finance Cyrus SA with a convertible bond loan of €1.0 million. |
| 2022-08-04 | Launch of the Honey Badger 50 (HB50) power system and fulfillment of the first shipment order from the U.S. Department of Defense. |
| 2023-05-24 | Company received a Nasdaq deficiency letter for bid price below $1.00 per share. |
| 2023-06-02 | Company entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC to sell up to $50 million of common stock. |
| 2023-09-14 | Shareholder demand letter received to inspect books and records related to the AMCI merger. |
| 2023-09-30 | Advent secured a new $2.2 million contract with the US DoD to optimize the Honey Badger 50 portable fuel cell system. |
| 2023-11-06 | Advent announced a term sheet agreement with Airbus for a joint benchmarking project regarding an optimized Ion Pair Membrane Electrode Assembly (MEA). |
| 2023-12-31 | Advent secured a new $2.8 million contract with the US DoD for advanced manufacturing processes for the HB50 system. |
| 2024-04-17 | Company received a Nasdaq deficiency letter for not timely filing its Annual Report on Form 10-K. |
| 2024-04-29 | Stockholders approved a 1-for-30 reverse stock split of common stock. |
| 2024-04-30 | Board approved a 1-for-30 reverse stock split of common stock. |
| 2024-05-13 | Effective date of the Reverse Stock Split with the Secretary of the Commonwealth of Massachusetts. |
| 2024-05-14 | Common Stock began trading on a split-adjusted basis on Nasdaq Capital Market. |
| 2024-05-24 | Company received a Nasdaq deficiency letter for not timely filing its Quarterly Report on Form 10-Q for Q1 2024. |
| 2024-05-24 | Purported shareholder entered into a tolling agreement with the Company and former directors of AMCI. |
| 2024-06-05 | Purported shareholder filed a putative class action complaint in the Delaware Court of Chancery. |
| 2024-06-29 | Company decided to abandon the facility at Hood Park to reduce costs. |
| 2024-06-30 | Lease expiration for Hood Park facility accelerated. |
| 2024-07-12 | Company formally requested to terminate the supply contract with BASF. |
| 2024-07-25 | Advent Technologies A/S was declared bankrupt by the court in Aalborg, Denmark. |
| 2024-08-13 | Company filed its Annual Report on Form 10-K. |
| 2024-08-16 | Company informed of an arbitration decision and award in favor of F.E.R. fischer Edelstahlrohre GmbH for approximately €4.5 million. |
| 2024-10-15 | Company filed its First Quarter 10-Q. |
| 2024-10-18 | Company received a Nasdaq deficiency letter for not meeting the minimum $2.5 million stockholders' equity requirement. |
| 2024-11-05 | Company entered into a term loan agreement with Agile Capital Funding, LLC for $594 thousand. |
| 2024-11-22 | Company received a Nasdaq deficiency letter for not timely filing its Quarterly Report on Form 10-Q for Q3 2024. |
| 2024-12-27 | Company filed its Third Quarter 10-Q. |
| 2025-02-19 | Advent and Airbus representatives met in Hamburg, Germany to kickoff Phase Two of the joint benchmarking project. |
| 2025-03-05 | European Climate, Infrastructure and Environment Executive Agency (CINEA) and Advent's Greek subsidiary signed the grant agreement for the RHyno Project, providing €34.5 million in non-dilutive funding. |
| 2025-03-11 | Parties agreed to terminate the supply agreement with BASF. |
| 2025-04-15 | Company paid off and refinanced the term loan from Agile Capital Funding, LLC, entering a new term loan for $870 thousand. |
| 2025-04-16 | Company received a letter from Nasdaq Staff advising conditional compliance with the stockholders' equity rule. |
| 2025-05-09 | Chris Kaskavelis, a former employee, filed a claim against Advent SA before the Athens First Instance Court. |
| 2025-06-20 | Company paid off and refinanced the term loan from Agile Capital Funding, LLC, entering a new term loan for $1.465 million. |
| 2025-07-01 | Company entered into a settlement agreement and release with F.E.R. fischer Edelstahlrohre GmbH. |
| 2025-07-17 | Company agreed with the bankruptcy trustee of Advent Technologies A/S to settle an outstanding claim of €10.4 million for €100 thousand. |
| 2025-07-31 | Liability of €11.8 million settled for €119 thousand, resulting in an $11.7 million gain. |
| 2025-08-01 | Company entered into a Securities Purchase Agreement with Hudson Global Ventures LLC for a $235 thousand convertible promissory note and pre-funded warrant. |
| 2025-08-06 | Company entered into a new enhanced license agreement with Triad National Security, LLC for the Ion Pair technology. |
| 2025-08-12 | Company filed its Second Quarter 10-Q. |
| 2025-08-14 | Company entered into a purchase agreement with Hudson Global Ventures LLC to sell up to $52 million worth of common stock over 24 months. |
| 2025-08-18 | Hudson Global Ventures, LLC executed a warrant, resulting in the issuance of 131,348 shares of common stock. |
| 2025-08-18 | Company received a delist determination letter from Nasdaq Staff for not satisfying conditions to regain compliance with the stockholders' equity rule. |
| 2025-08-28 | Company entered into a securities purchase agreement with Hudson Global Ventures LLC for a $418 thousand convertible promissory note and pre-funded warrant. |
| 2025-09-11 | Company repaid all amounts owed pursuant to the $418 thousand Promissory Note with Hudson Global Ventures LLC. |
| 2025-09-30 | End of the reporting period for the 10-Q filing. |
| 2025-10-20 | Hearing scheduled for the claim filed by former employee Chris Kaskavelis against Advent SA. |
| 2025-10-22 | Annual meeting of stockholders held, approving election of directors, auditor ratification, potential issuance of 20% or more common stock to Hudson, and amendment to the 2021 Incentive Plan. |
| 2025-10-28 | Company received notice from Nasdaq of delisting proceedings for common stock and warrants. |
| 2025-10-29 | Marc Seelenfreund resigned from the Board of Directors. |
| 2025-10-30 | Joseph Celia resigned from the Board of Directors. Trading in securities suspended on Nasdaq, effective this date. |
| 2025-11-05 | Company repaid all amounts owed pursuant to the $235 thousand Promissory Note with Hudson Global Ventures LLC. |
| 2025-11-07 | Common Stock began trading on the OTCQB market under ADNH, and Public Warrants under ADNHW. |
| 2025-11-17 | Date of signing for the 10-Q report. |
| 2025-12-15 | Deadline for the Company to return 473 sqm of membrane (stored at BASF) and 4,000 sqm of membrane from its Patras facility to BASF. |
| 2026-02-27 | Maturity date for the $1.465 million term loan with Agile Capital Funding, LLC. |
| 2026-06-30 | Deadline for reduced settlement amount payment to F.E.R. fischer Edelstahlrohre GmbH. |
| 2026-07-01 | Maturity date for the $235 thousand convertible promissory note with Hudson Global Ventures LLC (repaid Nov 5, 2025). |
| 2026-08-01 | Maturity date for the $418 thousand convertible promissory note with Hudson Global Ventures LLC (repaid Sept 11, 2025). |
| 2026-08-31 | Maturity date for short-term promissory notes with company executives and officers. |
| 2026-12-18 | Maturity date for the $870 thousand term loan with Agile Capital Funding, LLC. |
Recommendation
strong sellThe company faces severe financial distress, evidenced by a 'going concern' warning, a substantial negative working capital, and a recent delisting from Nasdaq to the OTC market. While a one-time gain from a legal settlement boosted net income, core revenues have plummeted, and operating activities continue to consume cash. The reliance on high-interest, short-term debt and continuous equity raises (with significant dilution potential) indicates a desperate need for capital. Material weaknesses in internal controls further compound the risk. Given these fundamental issues, the stock presents an extremely high-risk profile with significant downside potential, making it a strong sell for investors.
Keywords
Fuel Cell, Hydrogen Technology, Membrane Electrode Assembly, MEA, HT-PEM, Renewable Energy, Portable Power, Stationary Power, Aviation Fuel Cell, EU Innovation Fund, Department of Defense, Nasdaq Delisting, Going Concern, Liquidity Crisis, Convertible Debt, Equity Raise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.